Four-Year Results: The EVOLUT Low Risk Trial
June 12, 2024 | Michael J. Reardon and C. Michael Gibson discuss the trial's 4-year results in low-surgical-risk patients with severe aortic stenosis randomized to self-expanding TAVI or SAVR. |
TCTMD Talking Points
2024-06-12T11:00:00Z